Earnings calls

Zydus Lifesci. concall ledger

Every earnings call for ZYDUSLIFE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ZYDUSLIFE · 4 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 10 Feb 2026Call held 10 Feb 2026

ZYDUSLIFE Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,860 cr+30% YoYConsolidated EBITDA₹1,820 cr+31% YoYConsolidated EBITDA Margin26.5%Adjusted Net Profit₹1,110 cr+9% YoY

Consolidated Revenue ₹6,860 cr (+30% YoY); Consolidated EBITDA ₹1,820 cr (+31% YoY); Consolidated EBITDA Margin 26.5% (+0% YoY). Consolidated revenues of ₹68.6 billion, up 30% YoY.

Read full transcript & analysis

Q2 FY26Published 06 Nov 2025Call held 06 Nov 2025

ZYDUSLIFE Q2 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,120 cr+17% YoYEBITDA₹2,020 cr+38% YoYEBITDA Margin32.9%+5% YoYNet Profit₹1,260 cr+38% YoY

Consolidated Revenue ₹6,120 cr (+17% YoY); EBITDA ₹2,020 cr (+38% YoY); EBITDA Margin 32.9% (+5% YoY). Consolidated revenues of ₹61.2 billion, up 17% YoY.

Read full transcript & analysis

Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

ZYDUSLIFE Q1 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹6,570 cr+6% YoYEBITDA₹2,090 crEBITDA Margin31.8%Net Profit₹1,470 cr+3% YoY

Consolidated Revenue ₹6,570 cr (+6% YoY); EBITDA ₹2,090 cr; EBITDA Margin 31.8%. Consolidated revenues of ₹65.7 billion, up 6% YoY.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

ZYDUSLIFE Q4 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue232.4 billion rupees+19% YoYConsolidated EBITDA70.6 billion rupees+31% YoYEBITDA Margin32.6%Net Profit47.5 billion rupees+22% YoY

Consolidated Revenue (FY25) 232.4 billion rupees (+19% YoY); Consolidated EBITDA (FY25) 70.6 billion rupees (+31% YoY); EBITDA Margin (Q4 FY25) 32.6%. FY25 consolidated revenues grew 19% YoY to ₹232.4 billion.

Read full transcript & analysis